ZimVie Inc. (NASDAQ:ZIMV) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lessened its holdings in shares of ZimVie Inc. (NASDAQ:ZIMV) by 23.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 419,899 shares of the company’s stock after selling 126,603 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in ZimVie were worth $5,858,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Bailard Inc. grew its position in shares of ZimVie by 35.0% during the fourth quarter. Bailard Inc. now owns 21,194 shares of the company’s stock worth $296,000 after buying an additional 5,494 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in ZimVie by 0.9% during the 4th quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company’s stock worth $1,404,000 after acquiring an additional 943 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of ZimVie by 9.8% in the 4th quarter. Principal Financial Group Inc. now owns 19,054 shares of the company’s stock worth $266,000 after purchasing an additional 1,702 shares during the last quarter. Rhumbline Advisers raised its stake in shares of ZimVie by 3.0% in the 4th quarter. Rhumbline Advisers now owns 45,214 shares of the company’s stock valued at $631,000 after purchasing an additional 1,303 shares in the last quarter. Finally, EMC Capital Management lifted its position in shares of ZimVie by 47.0% during the fourth quarter. EMC Capital Management now owns 13,802 shares of the company’s stock worth $193,000 after purchasing an additional 4,414 shares during the last quarter. 95.63% of the stock is currently owned by hedge funds and other institutional investors.

ZimVie Stock Performance

ZIMV stock opened at $11.49 on Tuesday. The stock’s 50 day simple moving average is $13.27 and its 200 day simple moving average is $14.16. ZimVie Inc. has a 12-month low of $11.32 and a 12-month high of $22.40. The firm has a market cap of $318.01 million, a P/E ratio of -0.88 and a beta of 2.10. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57.

ZimVie (NASDAQ:ZIMV) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.02. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The company had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. As a group, equities research analysts predict that ZimVie Inc. will post 0.6 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reissued a “hold” rating on shares of ZimVie in a report on Thursday, March 13th.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.